@article {Prieto00336-2022, author = {Miguel D. Prieto and Mosaab E. Alam and Alessandro N. Franciosi and Bradley S. Quon}, title = {Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis}, volume = {9}, number = {1}, elocation-id = {00336-2022}, year = {2023}, doi = {10.1183/23120541.00336-2022}, publisher = {European Respiratory Society}, abstract = {Background People living with cystic fibrosis have an increased risk of lung infection with nontuberculous mycobacteria (NTM), the prevalence of which is reportedly increasing. We conducted a systematic review of the literature to estimate the burden (prevalence and incidence) of NTM in the cystic fibrosis population.Methods Electronic databases, registries and grey literature sources were searched for cohort and cross-sectional studies reporting epidemiological measures (incidence and prevalence) of NTM infection or NTM pulmonary disease in cystic fibrosis. The last search was conducted in September 2021; we included reports published since database creation and registry reports published since 2010. The methodological quality of studies was appraised with the Joanna Briggs Institute tool. A random effects meta-analysis was conducted to summarise the prevalence of NTM infection, and the remaining results are presented in a narrative synthesis.Results This review included 95 studies. All 95 studies reported on NTM infection, and 14 of these also reported on NTM pulmonary disease. The pooled estimate for the point prevalence of NTM infection was 7.9\% (95\% CI 5.1{\textendash}12.0\%). In meta-regression, sample size and geographical location of the study modified the estimate. Longitudinal analysis of registry reports showed an increasing trend in NTM infection prevalence between 2010 and 2019.Conclusions The overall prevalence of NTM infection in cystic fibrosis is 7.9\% and is increasing over time based on international registry reports. Future studies should report screening frequency, microbial identification methods and incidence rates of progression from NTM infection to pulmonary disease.This systematic review and meta-analysis of the burden of nontuberculous mycobacteria in individuals with cystic fibrosis found that the worldwide prevalence of infection is \~{}8\% https://bit.ly/3dhmGvu}, URL = {https://openres.ersjournals.com/content/9/1/00336-2022}, eprint = {https://openres.ersjournals.com/content/9/1/00336-2022.full.pdf}, journal = {ERJ Open Research} }